Royalty Pharma (RPRX) PT Lowered to $41 at UBS

August 9, 2023 9:23 AM EDT Send to a Friend

UBS analyst Ashwani Verma lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Royalty Pharma (RPRX) PT Lowered to $41 at UBS

Member Login

Free News Feed